This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200706-832OCv1 177/3/261    most recent Alert me when this article is cited Alert me if a correction is posted Services Related articles in AJRCCM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bates, J. H. T. Articles by Irvin, C. G. Search for Related Content PubMed PubMed Citation Articles by Bates, J. H. T. Articles by Irvin, C. G.

The Synergistic Interactions of Allergic Lung Inflammation and Intratracheal Cationic Protein

¹ Vermont Lung Center, ² Department of Medicine, and ³ Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, Vermont

Correspondence and requests for reprints should be addressed to Dr. Jason H.T. Bates, Ph.D., HSRF 228, 149 Beaumont Avenue, Burlington, VT 05405-0075. E-mail: jason.h.bates{at}uvm.edu

Rationale: Airways hyperresponsiveness (AHR) is a hallmark feature of asthma, and can be caused by various disparate mechanisms. Mouse models of AHR have been useful for studying these mechanisms in isolation, but such models still typically do not exhibit the same degree of AHR as seen in severe human asthma. We hypothesized that more severe AHR in mice could be achieved by imbuing them with more than one mechanism of AHR.

Objectives: We sought to determine if the airway wall thickening accompanying allergic inflammation and the exaggerated smooth muscle shortening induced by intratracheal cationic protein could act together to produce a severe form of AHR.

Methods: We used the forced oscillation technique to measure methacholine responsiveness in BALB/c mice that had been sensitized and challenged with ovalbumin followed by an intratracheal instillation of poly-L-lysine.

Measurements and Main Results: We found that both ovalbumin and poly-L-lysine treatment alone caused moderate levels of AHR. When the two treatments were combined, however, they synergized in terms of their effect on lung stiffness to an extent that could even be fatal, reflecting a significantly enhanced level of airway closure.

Conclusions: Our results suggest that mechanistic synergy between airway wall thickening and exaggerated smooth muscle shortening produces a more germane mouse model of asthma that may have particular relevance to the pathophysiology of the acute severe asthma exacerbation.

Key Words: airway hyperresponsiveness • methacholine • mouse model • asthma exacerbation

AT A GLANCE COMMENTARY Scientific Knowledge on the Subject The causes of asthma attacks are unknown, despite the evidence that such attacks may simultaneously involve both the lung periphery and the central airways. What This Study Adds to the Field Exaggerated central airway constriction on a background of lung inflammation can cause extreme decrement in lung function, and even death, in mice. This is due to a synergy between smooth muscle shortening and airway wall thickening.

 

Related articles in AJRCCM:

At Last! A Realistic Animal Model of Severe Asthma

Peter T. Macklem
AJRCCM 2008 177: 245-246. [Full Text]  

This article has been cited by other articles:

				E. L. Kramer, E. M. Mushaben, P. A. Pastura, T. H. Acciani, G. H. Deutsch, G. K. Khurana Hershey, T. R. Korfhagen, W. D. Hardie, J. A. Whitsett, and T. D. Le Cras Early Growth Response-1 Suppresses Epidermal Growth Factor Receptor-Mediated Airway Hyperresponsiveness and Lung Remodeling in Mice Am. J. Respir. Cell Mol. Biol., October 1, 2009; 41(4): 415 - 425. [Abstract] [Full Text] [PDF]

				J. H. T. Bates, M. Rincon, and C. G. Irvin Animal models of asthma Am J Physiol Lung Cell Mol Physiol, September 1, 2009; 297(3): L401 - L410. [Abstract] [Full Text] [PDF]

				J. H. T. Bates, S. R. Bullimore, A. Z. Politi, J. Sneyd, R. C. Anafi, and A. -M. Lauzon Transient oscillatory force-length behavior of activated airway smooth muscle Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L362 - L372. [Abstract] [Full Text] [PDF]

				W. C. Moore Update in Asthma 2008 Am. J. Respir. Crit. Care Med., May 15, 2009; 179(10): 869 - 874. [Full Text] [PDF]

				C. G. Irvin and J. H. T. Bates Physiologic Dysfunction of the Asthmatic Lung: What's Going On Down There, Anyway? Proceedings of the ATS, May 1, 2009; 6(3): 306 - 311. [Abstract] [Full Text] [PDF]

				K. Ckless, A. Lampert, J. Reiss, D. Kasahara, M. E. Poynter, C. G. Irvin, L. K. A. Lundblad, R. Norton, A. van der Vliet, and Y. M. W. Janssen-Heininger Inhibition of Arginase Activity Enhances Inflammation in Mice with Allergic Airway Disease, in Association with Increases in Protein S-Nitrosylation and Tyrosine Nitration J. Immunol., September 15, 2008; 181(6): 4255 - 4264. [Abstract] [Full Text] [PDF]

				P. T. Macklem At Last! A Realistic Animal Model of Severe Asthma Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 245 - 246. [Full Text] [PDF]